MOLN Wutah bathi saben saham ing taun lumaku molecularpartners.com

Simbol resmi perusahaan Molecular Partners AG (MOLN)

Molecular Partners AG (MOLN) is vulnerable to European logistics disruptions and patent disputes. A comparison of EPS with the same period last year demonstrates revenue dynamics, where the 18.70 level represents the current value. High competition in targeted therapy creates risks of trial failures; however, Switzerland's stable jurisdiction and the humanitarian status of the research provide the company with reliable protection against sanctions pressure.

Wutah bathi resik saben saham ing taun iki Molecular Partners Ltd (MOLN): kanggo periode 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan Molecular Partners AG (MOLN)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan Molecular Partners Ltd|MOLN - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Molecular Partners|MOLN - Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Molecular Partners|MOLN - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku molecularpartners.com|MOLN - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Utang Agregat marang Ekuitas Molecular Partners AG|MOLN - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal molecularpartners.com|MOLN - Utang perusahaan|Rasio utang marang aset resik Molecular Partners|MOLN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Molecular Partners|Koefisien jangkoan perantara molecularpartners.com
- rincian bathi lan kelipatan pasar:
MOLN - Bathi resik perusahaan|Bathi mangsa ngarep Molecular Partners AG|MOLN - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Molecular Partners Ltd|MOLN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Molecular Partners|MOLN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Molecular Partners|MOLN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan molecularpartners.com|MOLN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Molecular Partners AG
- statistik dodolan lan pendapatan perusahaan:
MOLN - Pendapatan perusahaan|Prakiraan pendapatan perusahaan molecularpartners.com|MOLN - Multiplikator P/S|Multiplikator Forward P/S Molecular Partners
Analisis dhasar perusahaan:Molecular Partners Ltd (MOLN)
Sampel barang Molecular Partners AG

This metric measures the year-over-year dynamics of net earnings per share, reflecting capital generation efficiency and the growth rate of shareholder returns for Molecular Partners AG (MOLN). Analyzing the annual EPS change scale allows for an assessment of the commercialization of the unique DARPin protein architecture, determining the extent to which deep tumor penetration of drugs converts into actual financial results within the targeted therapy segment.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku GERN (Geron Corp)|Wutah bathi saben saham ing taun lumaku Nanobiotix Corp|Wutah bathi saben saham ing taun lumaku BCYC|Wutah bathi ing taun lumaku CTMX|Wutah bathi ing taun lumaku perspectivetherapeutics.com (CATX)|Genelux - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku ONCY (Oncolytics Biotech, Inc.)|Lisata - Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku MBRX|galeratx.com (GRTX) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku mtem.com (MTEM)